These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Canine transmissible venereal tumour: a morphological and immunohistochemical study of 11 tumours in growth phase and during regression after chemotherapy. Gonzalez CM, Griffey SM, Naydan DK, Flores E, Cepeda R, Cattaneo G, Madewell BR. J Comp Pathol; 2000 May; 122(4):241-8. PubMed ID: 10805977 [Abstract] [Full Text] [Related]
7. Does the tumour microenvironment alter tumorigenesis and clinical response in transmissible venereal tumour in dogs? Ballestero Fêo H, Montoya Flórez L, Yamatogi RS, Prado Duzanski A, Araújo JP, Oliveira RA, Rocha NS. Vet Comp Oncol; 2018 Sep; 16(3):370-378. PubMed ID: 29508538 [Abstract] [Full Text] [Related]
8. Predictive factors for the regression of canine transmissible venereal tumor during vincristine therapy. Scarpelli KC, Valladão ML, Metze K. Vet J; 2010 Mar; 183(3):362-3. PubMed ID: 19109042 [Abstract] [Full Text] [Related]
9. A Clinico-pathological study on the effect of vincristine on transmissible venereal tumour in dogs. Nak D, Nak Y, Cangul IT, Tuna B. J Vet Med A Physiol Pathol Clin Med; 2005 Sep; 52(7):366-70. PubMed ID: 16109105 [Abstract] [Full Text] [Related]
10. Primary intranasal transmissible venereal tumour in the dog: a retrospective study of six spontaneous cases. Papazoglou LG, Koutinas AF, Plevraki AG, Tontis D. J Vet Med A Physiol Pathol Clin Med; 2001 Sep; 48(7):391-400. PubMed ID: 11599677 [Abstract] [Full Text] [Related]
11. Transmissible venereal tumor: a retrospective study of 29 cases. Rogers KS, Walker MA, Dillon HB. J Am Anim Hosp Assoc; 1998 Sep; 34(6):463-70. PubMed ID: 9826280 [Abstract] [Full Text] [Related]
12. Cell cycle kinetics, apoptosis rates and gene expressions of MDR-1, TP53, BCL-2 and BAX in transmissible venereal tumour cells and their association with therapy response. Flórez MM, Fêo HB, da Silva GN, Yamatogi RS, Aguiar AJ, Araújo JP, Rocha NS. Vet Comp Oncol; 2017 Sep; 15(3):793-807. PubMed ID: 26879698 [Abstract] [Full Text] [Related]
13. Primary transmissible venereal tumour in the nasal cavity of a dog. Ginel PJ, Molleda JM, Novales M, Martín E, Margarito JM, López R. Vet Rec; 1995 Mar 04; 136(9):222-3. PubMed ID: 7771073 [No Abstract] [Full Text] [Related]
17. Canine transmissible venereal tumour: assessment of mast cell numbers as indicators of the growth phase. Mukaratirwa S, Chiwome T, Chitanga S, Bhebhe E. Vet Res Commun; 2006 Aug 04; 30(6):613-21. PubMed ID: 16838203 [Abstract] [Full Text] [Related]
18. Vincristine modulates the expression of Ki67 and apoptosis in naturally occurring canine transmissible venereal tumor (TVT). Özalp GR, Zik B, Bastan A, Peker S, Özdemir-Salci ES, Bastan I, Darbaz I, Salar S, Karakas K. Biotech Histochem; 2012 Jul 04; 87(5):325-30. PubMed ID: 22404564 [Abstract] [Full Text] [Related]
19. Chemotherapeutic management of transmissible venereal tumors in 30 dogs. Brown NO, Calvert C, MacEwen EG. J Am Vet Med Assoc; 1980 May 15; 176(10 Pt 1):983-6. PubMed ID: 7380719 [Abstract] [Full Text] [Related]
20. Canine transmissible venereal tumor and seminoma: a cytohistopathology and chemotherapy study of tumors in the growth phase and during regression after chemotherapy. Javanbakht J, Pedram B, Taheriyan MR, Khadivar F, Hosseini SH, Abdi FS, Hosseini E, Moloudizargari M, Aghajanshakeri SH, Javaherypour S, Shafiee R, Emrani Bidi R. Tumour Biol; 2014 Jun 15; 35(6):5493-500. PubMed ID: 24557542 [Abstract] [Full Text] [Related] Page: [Next] [New Search]